Yasushi Onishi

Sendai, 9808574, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 180 publications

Development and Clinical Application of a Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Method for Patients with Graft-versus-Host Disease to Quantify the Plasma Concentrations of Ruxolitinib and Posaconazole.

Development and Clinical Application of a Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Method for Patients with Graft-versus-Host Disease to Quantify the Plasma Concentrations of Ruxolitinib and Posaconazole.

Journal: Biological & pharmaceutical bulletin

Published: February 15, 2026

The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis.

The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis.

Journal: Transplantation proceedings

Published: January 23, 2026

Extramedullary blast crisis limited to the lymph nodes in chronic myeloid leukemia with a T/myeloid mixed phenotype

Extramedullary blast crisis limited to the lymph nodes in chronic myeloid leukemia with a T/myeloid mixed phenotype

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 12, 2026

Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation.

Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation.

Journal: Experimental hematology

Published: January 08, 2026

Are matched-related donors always the best choice? A retrospective study exploring the potential of umbilical cord blood.

Are matched-related donors always the best choice? A retrospective study exploring the potential of umbilical cord blood.

Journal: International journal of hematology

Published: December 13, 2025

Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia.

Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia.

Journal: International journal of hematology

Published: November 03, 2025

Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study.

Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study.

Journal: Bone marrow transplantation

Published: August 14, 2025

Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial.

Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial.

Journal: British journal of haematology

Published: August 04, 2025

Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia.

Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia.

Journal: American journal of hematology

Published: June 20, 2025

Erratum for Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma Developing Renal AA Amyloidosis: A Case Report and Literature Review.

Erratum for Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma Developing Renal AA Amyloidosis: A Case Report and Literature Review.

Journal: Internal medicine (Tokyo, Japan)

Published: June 15, 2025

Has early mortality following single-unit unrelated cord blood transplantation improved in recent years? A nationwide registry data analysis from 2003 to 2022 in Japan.

Has early mortality following single-unit unrelated cord blood transplantation improved in recent years? A nationwide registry data analysis from 2003 to 2022 in Japan.

Journal: British journal of haematology

Published: June 10, 2025

Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT.

Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT.

Journal: British journal of haematology

Published: May 26, 2025

Showing 1-12 of 180

Last Updated: 09/26/2026